About Asta Bio
Our technology combines 211-Astatine, the most druggable alpha-emitting radioisotope, with our proprietary Radiobody™ targeting molecules. This innovative approach ensures precise radiation delivery, destroying tumor cells by breaking their DNA strands without harming surrounding healthy cells.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
Undisclosed
Tracked Since
Oct 11, 2026
Web & Domain Identity
Official Website
astabiotx.com
Domain Registered Date
Mar 27, 2024
Social & Network Presence
X / Twitter Profile
@team
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Milestone
Website domain registered
astabiotx.com
Investors & Backers
IndieBio
Funding History
Venture Round
· Undisclosed
Backers: IndieBio
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026